What if there was a version of resveratrol that actually worked? One that your body could absorb, that stayed in your bloodstream long enough to matter, and that had real human clinical trial data behind it? That compound exists. It’s called pterostilbene โ and it’s what resveratrol wishes it could be.
๐ Simple Summary
Pterostilbene is a natural compound found in blueberries and grapes. It’s a close cousin of resveratrol โ the famous “red wine molecule” โ but with one massive advantage: your body can actually absorb and use it. Where resveratrol breaks down in minutes, pterostilbene stays active for hours.
The evidence shows pterostilbene fights inflammation, protects cells from damage, and may help with brain health, heart health, and metabolic function. Human trials are still limited, but the data we do have is encouraging โ especially when it’s paired with nicotinamide riboside (NR) as part of a combined supplement. The research community is paying attention because pterostilbene activates the same longevity pathways as resveratrol, but actually reaches meaningful levels in human blood.
If you’ve ever been disappointed by resveratrol, pterostilbene is the upgrade you should know about.
๐ฅ Evidence Tier: Silver โ Promising
Why Silver? Pterostilbene has stronger pharmacokinetics than resveratrol (4ร higher bioavailability, 7ร longer half-life), multiple human clinical trials showing safety and specific benefits, and a large body of compelling preclinical research across aging-relevant pathways. However, no standalone human longevity trial exists yet โ most human data comes from the combined NR+pterostilbene product (Basis), and we still need more direct evidence for pterostilbene alone on hard aging endpoints.
โ๏ธ At a Glance: Pros & Cons
โ ๏ธ We are researchers, not doctors. Nothing on this page is medical advice. Talk to your doctor before taking any supplement. The information below is for education only.
โ Pros (What the Evidence Supports)
- Superior bioavailability: Pterostilbene has 80% bioavailability vs. 20% for resveratrol, with a 7ร longer half-life โ meaning it actually reaches therapeutic levels in humans.
- NAD+ synergy: Combined with nicotinamide riboside (NR), pterostilbene reduces liver inflammation in NAFLD patients and improves menopause symptoms in clinical trials.
- Multi-pathway protection: Activates Nrf2 (antioxidant defense), SIRT1 (longevity pathway), and PPAR-ฮฑ (fat metabolism) โ hitting multiple aging hallmarks simultaneously.
- Strong safety record: 200 mg/day for 2 months showed no adverse effects in a double-blind RCT. Well-tolerated across multiple human trials.
โ Cons (What the Evidence Doesn’t Support or Warns About)
- No standalone human longevity trial: Most human data uses pterostilbene combined with NR โ pure pterostilbene human longevity data is still lacking.
- LDL cholesterol concern: Like resveratrol, pterostilbene may raise LDL cholesterol at high doses in some individuals โ one human study noted this, though it was not statistically significant.
- Dose uncertainty: Optimal dose for longevity is unknown. Human trials used 50โ200 mg/day โ animal studies often used much higher equivalent doses.
- Drug interactions: Pterostilbene affects liver enzymes (CYP450) and may interact with blood thinners, blood pressure medications, and chemotherapy drugs.
What Is Pterostilbene?
Pterostilbene (pronounced “tero-STILL-bean”) is a stilbenoid โ the same chemical family as resveratrol. It’s found naturally in blueberries, grapes, almonds, and the bark of the Pterocarpus marsupium tree (Indian kino). Structurally, it’s resveratrol with two extra methyl groups โ and those two tiny additions change everything.
Those methyl groups make pterostilbene more fat-soluble, which means it crosses cell membranes more easily, resists breakdown by the liver, and sticks around in your bloodstream roughly 7 times longer than resveratrol. This is the single most important thing to understand about pterostilbene: the difference between it and resveratrol isn’t subtle. It’s the difference between a compound that gets destroyed before it can do anything and one that actually reaches your cells.
How It Works
Pterostilbene works through several overlapping mechanisms that are directly relevant to aging:
Nrf2 Activation (Antioxidant Defense): Pterostilbene is one of the most potent natural activators of Nrf2, the “master switch” for your body’s antioxidant and detoxification systems. When Nrf2 is activated, it turns on genes that produce glutathione, superoxide dismutase, and other protective enzymes. A 2026 comprehensive review confirmed that pterostilbene’s effects “cannot be explained solely by direct ROS scavenging” โ it’s actually reprogramming your cells to defend themselves (PMID: 42404708).
SIRT1 Activation (Longevity Pathway): Like resveratrol, pterostilbene activates SIRT1 โ a sirtuin protein linked to lifespan extension in multiple organisms. SIRT1 is the same pathway that calorie restriction activates, and it’s one of the most studied longevity targets in biology. Pterostilbene appears to activate SIRT1 more potently than resveratrol at lower concentrations.
PPAR-ฮฑ Agonism (Fat Metabolism): Pterostilbene activates PPAR-alpha, a receptor that regulates how your body processes fats. This is one mechanism that distinguishes it from resveratrol and likely contributes to its beneficial effects on lipid profiles and liver health. In the 2023 NAFLD clinical trial, the combination of NR and pterostilbene significantly reduced liver enzyme levels and a toxic lipid called ceramide 14:0 (PMID: 36082508).
Anti-inflammatory Effects: Pterostilbene suppresses NF-ฮบB, a master inflammation switch that becomes chronically activated with age. By dialing down NF-ฮบB, pterostilbene reduces the background inflammation (“inflammaging”) that drives most age-related diseases.
Mitochondrial Protection: Research shows pterostilbene improves mitochondrial membrane potential and ATP production, particularly in aging cells. In a 2025 mouse study, pterostilbene restored mitochondrial function in aged oocytes (egg cells), improving reproductive outcomes โ a finding that hints at broader anti-aging effects on cellular energy systems (PMID: 40711451).
The Longevity Connection
๐ง Brain Health & Neuroprotection
Pterostilbene crosses the blood-brain barrier more effectively than resveratrol, making it particularly interesting for brain aging. Animal studies show it reduces neuroinflammation after stroke (PMID: 39198723, 37614235), and a 2026 study found that optimized pterostilbene derivatives improved cerebral blood flow and reduced brain damage in stroke models better than pterostilbene itself (PMID: 42196490). While human cognition trials are still lacking, the preclinical signal is consistent and strong.
โค๏ธ Cardiovascular Protection
A 2024 review concluded that pterostilbene’s “remarkable anti-inflammatory and antioxidant effects” position it as a promising cardiovascular therapeutic (PMID: 39329921). It reduces oxidative stress in blood vessel lining cells, suppresses inflammation-driven atherosclerosis, and improves lipid profiles. The human safety trial at 200 mg/day found no negative cardiovascular effects โ and while it didn’t show dramatic improvements either, the trial was designed for safety, not efficacy.
๐ซ Anti-Fibrotic Effects (Slowing Organ Aging)
Fibrosis โ the scarring and stiffening of tissues โ is a hallmark of aging in virtually every organ. A 2024 review identified pterostilbene as a multi-organ antifibrotic agent, showing benefits in lung, liver, kidney, heart, and colon fibrosis models (PMID: 38429613). This is particularly relevant to longevity because organ fibrosis is one of the major ways aging manifests as disease.
๐ซ Liver Health
The strongest human data for pterostilbene comes from liver health. In a 6-month double-blind RCT of 111 adults with NAFLD, NRPT (250 mg NR + 50 mg pterostilbene) significantly reduced ALT and GGT โ two key liver enzymes that indicate inflammation โ compared to placebo (PMID: 36082508). A 2026 mouse study confirmed pterostilbene protects the liver through gut-liver axis modulation, reducing inflammation and oxidative stress (PMID: 42444162).
๐ฉ Menopause Symptom Relief
In a 2026 open-label clinical trial, 32 women experiencing menopause symptoms took NRPT (250 mg NR + 50 mg pterostilbene) daily for 7 days. The results: significant decreases in bloating, hot flashes, and poor sleep. Notably, the estradiol-to-estrone ratio increased โ suggesting pterostilbene may help restore a more youthful hormone balance (PMID: 42211736).
๐ฆด Osteoarthritis & Joint Aging
Multiple recent studies (2025) show pterostilbene reduces cartilage destruction in osteoarthritis models by blocking inflammatory pathways and promoting autophagy โ the cellular cleanup process that declines with age (PMID: 40778537, 41075072).
Key Studies
| Study | Design | Key Finding |
|---|---|---|
| Dellinger et al., 2023 | 6-month RCT, 111 adults with NAFLD | NR + pterostilbene (250/50 mg) reduced liver enzymes ALT and GGT, and toxic ceramide 14:0 vs. placebo |
| Holmes et al., 2026 | 7-day open-label trial, 40 women | NR + pterostilbene significantly reduced bloating, hot flashes, and poor sleep in menopausal women; increased E2/E1 ratio |
| Majeed et al., 2023 | 2-month RCT, 60 healthy adults | 200 mg/day pterostilbene (90% extract) was safe with no adverse effects on blood markers, vital signs, or ECG |
| Okamoto et al., 2025 | Mouse study โ aged and middle-aged females | Pterostilbene restored oocyte mitochondrial function, improved implantation and live birth rates in aged mice |
| Freeberg et al., 2023 | Review of human NAD+ precursor trials | NR + pterostilbene combination was safe, tolerable, and increased NAD+ levels across multiple human studies |
| Gao et al., 2026 | Mouse โ multi-omics (metabolomics + microbiome) | Pterostilbene protected liver through gut-liver axis: reduced inflammation, restored beneficial gut bacteria, normalized metabolites |
Dosing and Safety
Recommended Protocol
| Parameter | Recommendation | Evidence |
|---|---|---|
| Dose | 50โ100 mg/day (standalone) or 50 mg/day (with NR) | Human trials used 50โ200 mg/day. 50 mg is the standard dose in NRPT/Basis |
| Timing | Morning, with food (contains fat) | Fat-soluble โ absorption improves with dietary fat |
| Form | Standardized extract (โฅ90% pterostilbene) | Safety established with Pterocarpus marsupium extract standardized to 90% |
| Cycling | No evidence requires cycling; 2-month continuous use confirmed safe | Majeed et al., 2023 |
| Stack with | Nicotinamide riboside (NR) or NMN for NAD+ synergy | Best human evidence is for NR+PT combination |
Side Effects
| Side Effect | Frequency | Notes |
|---|---|---|
| Mild GI discomfort | Uncommon | Taking with food usually resolves |
| LDL cholesterol increase | Possible at high doses | One human study noted a trend; not statistically significant. Monitor if you have cholesterol concerns |
| Blood thinning | Theoretical | Pterostilbene has mild anti-platelet activity in lab studies โ caution with blood thinners |
โ Common Questions About Pterostilbene
What is pterostilbene and how does it work?
Pterostilbene is a natural compound found in blueberries and grapes โ it’s a more absorbable version of resveratrol. It works by activating your body’s built-in defense systems: it turns on Nrf2 (your antioxidant master switch), activates SIRT1 (a longevity protein linked to calorie restriction), and reduces chronic inflammation by dialing down NF-ฮบB. Because it has two extra methyl groups compared to resveratrol, it crosses cell membranes easily and stays in your bloodstream about 7 times longer.
What does the evidence actually show?
The evidence falls into two buckets. In human trials, pterostilbene combined with nicotinamide riboside (NR) reduced liver inflammation in people with fatty liver disease and improved menopause symptoms. Pterostilbene alone at 200 mg/day was confirmed safe in a 2-month trial. In animal studies, it protects the brain after stroke, restores egg cell quality in aged female mice, reduces organ scarring (fibrosis), and improves metabolic health across multiple organs. No direct human longevity trial exists yet โ that’s the biggest evidence gap.
What’s the right dose?
Human trials have used 50โ200 mg per day safely. The standard dose in the well-studied NRPT (Basis) combination is 50 mg of pterostilbene with 250 mg of nicotinamide riboside. If taking pterostilbene alone, 100 mg/day is a reasonable starting point. Take it with food that contains some fat โ it’s fat-soluble, so absorption improves significantly. Morning dosing is most common since it can slightly increase energy.
What are the risks and side effects?
Pterostilbene has an excellent safety profile. In the largest safety trial (200 mg/day for 2 months), there were zero serious adverse events and no significant changes in blood work, vital signs, or heart function. The most common minor issue is mild stomach discomfort, which usually resolves when taken with food. There’s a theoretical concern about LDL cholesterol increases at very high doses โ one human study saw a trend in this direction, but it wasn’t statistically significant. If you have high cholesterol, monitor your levels.
Who should avoid it?
People on blood thinners (like warfarin) should be cautious โ pterostilbene has mild anti-platelet effects in lab studies. Those on multiple medications processed by the liver should consult a doctor because pterostilbene affects CYP450 liver enzymes and could change how other drugs are metabolized. Pregnant and breastfeeding women should avoid it due to a complete lack of safety data in these populations. Anyone undergoing chemotherapy should speak with their oncologist first โ pterostilbene’s effects on cancer cells vary by context and dose.
The Bottom Line
Pterostilbene is what resveratrol should have been โ a stilbenoid that actually reaches therapeutic levels in humans. The pharmacokinetic advantage is real and substantial: 80% bioavailability vs. 20%, 105-minute half-life vs. 14 minutes. Those numbers matter.
Where the evidence is strongest: Liver health (human RCT), menopause symptom relief (human trial), safety (multiple human trials), and broad-spectrum anti-inflammatory/antioxidant protection (consistent across dozens of preclinical studies).
Where we need more data: Direct human longevity endpoints, standalone pterostilbene efficacy trials (most human data uses the NR combination), and optimal dosing for aging-specific outcomes.
Our verdict: Pterostilbene earns its Silver tier honestly. It’s not a proven longevity drug, but it has a stronger evidence foundation than most supplements in the longevity space โ and its pharmacokinetic superiority over resveratrol makes it the clear choice if you’re choosing between the two. The combination with NR appears particularly promising based on human data. For people already taking an NAD+ precursor (NMN or NR), adding pterostilbene is one of the more evidence-supported stack decisions you can make.
Who it’s for: People interested in metabolic health, liver protection, inflammation control, and those already taking NAD+ precursors who want to boost their effectiveness. Also, anyone who tried resveratrol and was disappointed.
Medical Disclaimer: This information is for educational purposes only and is not medical advice. We are researchers, not doctors. Do not start, stop, or change any medication or supplement without consulting your healthcare provider. Pterostilbene can interact with prescription medications, particularly blood thinners and drugs metabolized by the liver. The FDA has not evaluated these statements.
Sources
- Freeberg KA et al. “Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions.” J Gerontol A Biol Sci Med Sci. 2023. PMID: 37068054
- Dellinger RW et al. “Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: A double-blind, placebo-controlled clinical trial.” Hepatology. 2023. PMID: 36082508
- Holmes HE et al. “Nicotinamide riboside and pterostilbene reduces frequency and severity of undesirable symptoms of the menopause transition: an open-label, pilot clinical trial.” Front Aging. 2026. PMID: 42211736
- Majeed M et al. “A Short-Term Safety Evaluation of Silbinolยฎ โ an Extract from Pterocarpus marsupium in Healthy Adults.” J Evid Based Integr Med. 2023. PMID: 37671486
- Okamoto N et al. “Pterostilbene enhances reproductive outcomes and oocyte quality in aged mice without adverse effects.” Aging (Albany NY). 2025. PMID: 40711451
- Zhang Y et al. “Pterostilbene in Oxidative Stress-Related Diseases: Context-Dependent Regulation of Redox Homeostasis and Translational Challenges.” Drug Des Devel Ther. 2026. PMID: 42404708
- Tian R et al. “Effects of Pterostilbene on Cardiovascular Health and Disease.” Curr Issues Mol Biol. 2024. PMID: 39329921
- Wang W et al. “Pterostilbene: a potential therapeutic agent for fibrotic diseases.” Inflammopharmacology. 2024. PMID: 38429613
- Gao H et al. “Multi-omics integration reveals that pterostilbene ameliorates cyclophosphamide-induced liver injury via the gut-liver axis.” Food Funct. 2026. PMID: 42444162
- Chen Y et al. “Pterostilbene improves neurological dysfunction and neuroinflammation after ischaemic stroke via HDAC3/Nrf1-mediated microglial activation.” Cell Mol Biol Lett. 2024. PMID: 39198723